Please login to the form below
EU
This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.
Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma
The Committee for Medicinal Products for Human Use (CHMP) has specifically recommended that the antibody-drug conjugate (ADC), which is already approved in the EU for certain lymphoma patients, be used ... The CHMP’s recommendation will now be reviewed
Latest news
-
EC approves Menarini Group’s Orserdu for advanced or metastatic breast cancer
The EU regulator’s decision specifically applies to postmenopausal women and men with oestrogen receptor (ER) positive, HER2-negative, locally advanced or metastatic breast cancer with an activating ESR1 mutation.
-
Gilead’s Veklury recommended by CHMP for COVID-19 in patients with hepatic impairment
Anu Osinusi, vice president, clinical research for hepatitis, respiratory and emerging viruses at Gilead, said: “Despite lower levels of COVID-19 circulating in the EU than at the height of the ... The European Commission will now review the CHMP’s
-
FDA boosts collaboration with manufacturers to overcome ongoing cancer drug shortages
Drug shortages have been an ongoing global issue. At the beginning of this year, the EU said it would be revising its pharmaceuticals law amid a growing number of antibiotic shortages.
-
World Atopic Eczema Day 2023: Almirall unveils awareness campaign
The inflammatory skin disease is estimated to affect 4.4% of adults in the EU. ... The incidence of atopic dermatitis appears to have increased in recent decades, currently affecting an estimated 4.4% of adults in the EU.
-
UK rejoins Horizon Europe research initiative under new bespoke agreement
The UK is set to rejoin the Horizon Europe research initiative through a bespoke new agreement with the EU. ... Following a discussion with EU Commission President, Ursula Von der Leyen, Sunak secured improved financial terms of association with Horizon
More from news
Approximately 148 fully matching, plus 2,464 partially matching documents found.
Latest Intelligence
-
Man vs microbe: the fight against antimicrobial resistance
It is estimated that in the EU alone, AMR is associated with EUR 1.5 billion annually in healthcare costs and productivity losses.
-
The impact of prostate cancer on global health
Based on the results of PROpel trial, olaparib plus abiraterone has been approved the EU and several other countries for the treatment of patients with mCRPC.
-
Driving market access through clinical trial diversity
The sea change had been building. EU drug regulators were placing increased emphasis on diversifying clinical trials through a fairer representation of gender and age groups.
-
The importance of accelerating clinical trial diversity
the EU, UK and US that are reframing clinical trials.
-
eCTD 4.0 is changing the regulatory landscape – what you need to know
CVs for application, submission and submission unit type CVs are relevant for the US, the EU and Japan. ... CV for category event submission type is relevant for Japan, and not for the US or the EU.
More from intelligence
Approximately 9 fully matching, plus 224 partially matching documents found.
Latest appointments
-
David Hunt launches independent agency The Considered
awards, including Cannes Lions Healthcare Agency of the Year, PMEA EU Healthcare Agency of the Year and Creative Floor Most Awarded Agency.
-
Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region
Benjamin Rapp, regional president EU South at Ashfield Engage.
-
EFPIA confirms first and second vice-presidents
I look forward to working with the EFPIA Board and the wider community to achieve the shared goal of building a future EU health and innovation union.”. ... Realising that goal means EFPIA and its membership working with the EU and Member States to
-
Hanover Health appoints Aleksandra Lugović as an associate director
Lugović joins from GOPA Com. Brussels, where she ran global campaigns for the European Commission across the EU, US, Africa and Asia. ... Prior to that, she headed the regional representation of South Serbia to the EU for a period of six years.
-
EFPIA appoints Hubertus von Baumbach as president
He added: “Over the coming months, my colleagues and I look forward to engaging with the EU Institutions and across Member States to discuss how we can work together to ensure ... that the EU remains an innovation leader and to build a healthier future
More from appointments
Approximately 2 fully matching, plus 68 partially matching documents found.
Latest from PMHub
-
World Environmental Health Day 2023
1 - European Environment Agency. Health. 2023. Available from https://www.eea.europa.eu/en/topics/at-a-glance/health [Accessed August 2023].
-
Article: War in the Blood - The battle takes shape in the burgeoning European oncology CAR-T market access space
In this article for pharmaphorum's Oncology Deep Dive, Research Partnership reviews the market access opportunities and challenges encountered by CAR-Ts commercialised in the EU-4 and the UK (see
-
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
When the EU passed the PSD2 Law in 2019, giving approved and regulated third-party businesses the permission to connect to banks and make payments on consumers’ behalf, it kick started
-
Rare Diseases - not as rare as you think
Julie Cox reflects on our passion working in the rare disease space - helping to bring vital education to healthcare professionals, to benefit patients. There are more than 7000 rare diseases affecting an estimated 3.5 million people in the UK. 1.
-
End-to-end patient strategy: Making a treatment for patients, with patients
Available at https://imi-paradigm.eu/survey/. Accessed November 2022. CDER Patient-Focused Drug Development. US Food and Drug Administration. ... Available at https://imi-paradigm.eu/wp-content/uploads/2020/09/PARADIGMD6.5_ PE-Sustainability-roadmap_FINAL
More from PMHub
Approximately 3 fully matching, plus 143 partially matching documents found.
Subscribe to our email news alerts
- Medscape Education’s Large Presence at IDWeek 2023
- WHO recommends second malaria vaccine for children
- Sanofi enters agreement with Janssen to develop E. coli vaccine candidate
- NFID and CDC urge US adults to get vaccinated against flu and COVID-19
- Man vs microbe: the fight against antimicrobial resistance
- Dollo's law
No results were found
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
- HOW TO TRANSFORM YOUR HEALTHCARE BRAND MARKETING FROM MULTI-CHANNEL TO OMNICHANNEL
- In a previous blog, we outlined the role of omnichannel in healthcare and the importance of personalised communications with the suggestion of using modular content to support an omnichannel approach....
